MedTrace Logo

Familial Myeloproliferative Disorders

NCT00666289 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 17

Last updated 2017-09-05

No results posted yet for this study

Summary

Myeloproliferative disorders occur in families, thus giving rise to the theory that it is a genetic disease that may be caused by an abnormal gene in the DNA that can be passed from one generation of family members to another. DNA can be gathered from family members through blood samples and the investigators will investigate (through DNA testing) to see if there are abnormal genes that may be responsible for causing the MPDs. Understanding which genes are responsible for causing MPDs can help develop ways to identify people who may be at risk for developing an MPD, allow for the development of better treatments, possibly a cure, or even prevent the development of MPDs.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Josef Prachal, MD · Myeloproliferative Disorders-Research Consortium

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2015-01-20
Completion
2015-06-20

Countries

  • United States
  • Italy

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00666289 on ClinicalTrials.gov